After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?
With its share price down 56% in the past 12 months, STAAR Surgical's (NASDAQ: STAA) stock has clearly seen better days. Judging by its collapse, it'd be reasonable to assume the implantable lens company is facing major headwinds -- but it isn't. In fact, there's not much standing in the way of its continued growth over time.
So is there another issue that should dissuade investors from approaching this stock? Perhaps, but rumors of STAAR's rolling demise are quite overblown, and here's why.
Image source: Getty Images.
Source Fool.com
